Keywords: call, fda, take, action, generic, clozapine, issue

Call for FDA to take action on generic clozapine issue

Article | 07 November 2000

Print This

A report in the Wall Street Journal, claiming that patients switchedfrom the branded form of an antipsychotic medication to a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in